Archive

Here you will find the contents of all past issues of Acumen, including feature stories, news, case studies, metrics, and more.

VOLUME 1, NUMBER 4 : NOVEMBER / DECEMBER 2003


The Looming Threat: And the Bioshield That Won’t Work
Bioweapons are much more prevalent and virulent than most of us realize. And we have little defense.

Soldiers and Nanotechnology
MIT joins the U. S. Army’s effort to create a future warrior battle suit. Here’s what they envision.

Profile: Military Intellectual
As professor of defense analysis at the Naval Postgraduate School, John Arquilla thinks deeply about wars past and future.

Better Living Through Chemistry
We all want to be happier. For some mentally ill people, achieving this state may mean a blood sample and a pillbox.

Investor Profile
Dr. Bala Manian

Opinion
BiodefenseMental HealthActivismAcademiaBy Invitation: Graham Allison, Ph.D.

News Analysis
China’s Soy PloyA Crack in the WindowGive Me Your Patents and Your PoorSurprise, SurpriseShow and TellWaiting to ExhaleThe Latest in BioterrorismBriefly Noted

Reviews
No Faustian BargainBuilding a Better BrainNew and Noteworthy

Metrics
BioMetricsPipelineCapital MarketsBioIndex

Case Studies
ImmunexCellGate

Synopses

Photo Essay: Cold Warriors

In Every Issue
Common SenseEditor's Letter

 

VOLUME 1, NUMBER 3 : SEPTEMBER / OCTOBER 2003


Biologics: Means to an End?
Even with genomics, the next generation of biological drugs will remain elusive. Plus, how the mighty gene stocks have fallen.

Dying to Be Politically Correct
As the global death toll for malaria rises again, the politics of the once-popular pesticide are to blame.

Community Property
With the Human Genome Project, intellectual property law and life sciences launched a partnership.

Prescription: Price Regulation
As drugs become more expensive, price controls are inevitable. What would such a world look like?

Investor Profile
Harlan Kleiman and Dr. Kate Winkler

Opinion
Paying for vital drugs for poor countriesOpen source for scienceAmerican GM foods in Europe need a carrot and a stickBy Invitation: Jay Oglivy

News Analysis
SARS Sequel?False PositivesMorality PlayA Bitter PillStress TestRare OpportunityShow and TellJoint by JointFile-o-FactsColumbia’s Lesson?Briefly Noted

Reviews
This is Your Brain on MoneyFood for Thought

Metrics
BioMetricsPipelineCapital MarketsBioIndex

Case Studies
CordisAllerganMonsanto

Synopses

Photo Essay: Baghdad

In Every Issue
Common SenseObituary: Kurt SemmEditor's Letter

 

VOLUME 1, NUMBER 2 : JULY / AUGUST 2003


Aging Gracelessly
The American system of financing chronic care is not sustainable for much longer.

The Pursuit of Longevity
Long-lived worms tantalize researchers with the promise of extended life.

How to Grow Old
A physician’s prescription for aging.

Designed to Live
Tom Kirkwood took up the evolutionary explanation of aging in part to fight what he says is gerontology’s greatest misconception: that we are programmed to die.

Ethical Dilemma
When solutions to biological quandaries stem from moral certitudes instead of give-and-take debate, public discourse suffers.

Investor Profile
Jeff Herrmann

Opinion
Health CareBioethicsPolicyPharmaceuticalsBy Invitation: Larry Brilliant

News Analysis
Ready or NotVive la Differentiation!Shrinking StaffsDouble AttackBull’s-Eye?Biotech BuysSniffing for SNPs

Reviews
Prescription for the FDAPerchance to DreamTheir Eyes Were Watching God

Metrics
BioMetricsPipelineCapital MarketsBioIndex

Case Studies
Amgen and Jonhson & JohnsonAstraZenecaGenentech

Synopses

Photo Essay: Bone Structures

In Every Issue
Common SenseObituary: Ira HerskowitzEditor's Letter

 

VOLUME 1, NUMBER 1 : MAY / JUNE 2003


No Cure for Alzheimer's
The Consequences of the Stem Cell Ban

Why Aren't There More Drugs?
How the Industrialization of the Life Sciences Failed

How to Save Africa
AIDS, Drugs and the Developing World

Investor Profile
Sam Colella

Venture Discovery
The Ellison Medical Foundation believes it can remove bureaucratic obstacles to research. Wishful thinking?

News Analysis
Preventive MedicineStarting SmallSARS StarSticklers for AccuracyNew Platforms for TherapeuticsGenetic Appetite

Reviews
DNA at 50The Genetic FrontierCloser to God

Metrics
BioMetricsPipelineCapital MarketsBioIndex

Case Studies
ImClone SystemsVaxGenMerck-Medco

Synopses

In Every Issue
Common SenseBy Invitation: Freeman DysonObituary: DollyEditor's Letter

News Archive